image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

P2Y1 receptor

Family: P2Y receptors

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Agonists
Antagonists
Allosteric Regulators
Transduction Mechanisms
Tissue Distribution
Expression Datasets
Functional Assays
Physiological Functions
Physiological Consequences of Altering Gene Expression
Phenotypes, Alleles and Disease Models
Biologically Significant Variants
General Comments
References
Gene and Protein Information
class A G protein-coupled receptor
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 7 373 3q25.2 P2RY1 purinergic receptor P2Y, G-protein coupled, 1 1,26
Mouse 7 373 3 E1 P2ry1 purinergic receptor P2Y, G-protein coupled 1 48
Rat 7 373 2q31 P2ry1 purinergic receptor P2Y, G-protein coupled, 1 48
Previous and Unofficial Names
P2Y
Purinergic receptor P2Y1
ATP receptor
P2Y purinoceptor 1
platelet ADP receptor
P2 purinoceptor subtype Y1
purinergic receptor P2Y G-protein coupled 1
P2Y1
P2y
P2 purinoreceptor subclass 2Y
P2Y ATP receptor 1
purinergic receptor P2Y, G-protein coupled 1
purinergic receptor P2Y, G-protein coupled, 1
P2Y1 receptor
Database Links
ChEMBL Target 10544 (Hs), 10545 (Rn)
Ensembl ENSG00000169860 (Hs), ENSMUSG00000027765 (Mm), ENSRNOG00000014232 (Rn)
Entrez Gene 5028 (Hs), 18441 (Mm), 25265 (Rn)
GeneCards P2RY1 (Hs)
GenitoUrinary Development Molecular Anatomy Project P2ry1 (Mm)
HomoloGene 1926 (Hs)
Human Protein Reference Database 03103 (Hs)
InterPro P47900 (Hs), P49650 (Mm), P49651 (Rn)
KEGG Gene hsa:5028 (Hs), mmu:18441 (Mm), rno:25265 (Rn)
OMIM 601167 (Hs)
PharmGKB Gene PA32868 (Hs)
PhosphoSitePlus P47900 (Hs), P49650 (Mm), P49651 (Rn)
Protein Ontology (PRO) PRO:000001568 (Hs)
RefSeq Nucleotide NM_002563 (Hs), NM_008772 (Mm), NM_012800 (Rn)
RefSeq Protein NP_002554 (Hs), NP_032798 (Mm), NP_036932 (Rn)
TreeFam ENSG00000169860 (Hs), ENSMUSG00000027765 (Mm), ENSRNOG00000014232 (Rn)
UniGene Hs. 654526 (Hs)
UniProt P47900 (Hs), P49650 (Mm), P49651 (Rn)
Wikipedia P2Y1 receptor
P2Y receptors
Search for 3D structures on the PDB
Search by keyword: P2Y receptors P2Y1 receptor Search by accession number: P49651, P47900, P49650
Natural/Endogenous Ligand(s)
ADP
ATP
Rank order of potency
ADP>ATP
Agonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
MRS2365 Hs Agonist 9.4 pEC50 7
ADPβS Hs Agonist 7.3 pEC50 46
2',3'-ddATP Hs Partial agonist 8.0 pIC50 41
dATPαS Hs Partial agonist 7.7 pIC50 41
ATPγS Hs Partial agonist 7.4 pIC50 41
2MeSATP Hs Partial agonist 6.4 – 7.6 pIC50 41,49
ATP Hs Partial agonist 6.1 – 7.8 pIC50 41,49
ADP Hs Full agonist 6.2 – 7.2 pIC50 41,49
2MeSADP Hs Full agonist 5.4 – 7.0 pIC50 41,49
Agonist Comments
ATP has been reported to be both a partial agonist [37] and an antagonist [22] (see Antagonist section).
Antagonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
[32P]MRS2500 Hs Antagonist 9.4 pKd 25
[3H]MRS2279 Hs Antagonist 8.1 pKd 49
MRS2500 Hs Antagonist 8.8 – 9.1 pKi 5,28
BMS Compound 16 [PMID:23368907] Hs Antagonist 8.2 pKi 6
Pfizer compound 67 [PMID:18445527] Hs Antagonist 8.0 pKi 38
MRS2279 Hs Antagonist 7.9 pKi 49
MRS2298 Hs Antagonist 7.5 pKi 5
Pfizer compound 11 [PMID:18445527] Hs Antagonist 7.3 pKi 38
GlaxoSmithKline compound 6i [PMID:18926700] Hs Antagonist 7.2 pKi 36
MRS2496 Hs Antagonist 7.1 pKi 5
MRS2179 Hs Antagonist 7.0 – 7.1 pKi 2,49
GlaxoSmithKline compound 5h [PMID:20542694] Hs Antagonist 6.85 pKi 47
2,2'-pyridylisatogen tosylate Hs Antagonist 6.8 pKi 17
2-ClATP Hs Antagonist 5.6 pKi 22
suramin Hs Antagonist 5.3 pKi 49
2MeSATP Hs Antagonist 5.2 pKi 22
PPADS Hs Antagonist 5.2 pKi 49
ATP Hs Antagonist 4.8 pKi 22
A2P5P Hs Antagonist 5.8 pEC50 2
adenosine-3'-5'-diphosphate Hs Antagonist 5.6 pEC50 2
A3P5PS Hs Antagonist 0.0 pEC50 2
MRS2950 Hs Antagonist 6.9 pIC50 8
Antagonist Comments
It is likely that ATP and derivatives (e.g., 2-ClATP and 2MeSATP) act as antagonist at P2Y1 rather than agonists. The apparent agonist action of these compounds may be due to impurity and to the rapid conversion to the diphosphate form [22]. High-throughput screening against the P2Y1 receptor identified a novel series of tetrahydro-4-quinolinamine antagonists [36].
Allosteric Regulators
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
2,2'-pyridylisatogen tosylate Hs Negative 7.8 pIC50 18

Explore drug-target interactions for this set of compounds using iPHACE

Primary Transduction Mechanisms
Transducer Effector/Response
Gq/G11 family Phospholipase C stimulation
Comments:  The activation of PLC leads to mobilisation of calcium from IP3-sensitive intracellular stores.
References:  10
Secondary Transduction Mechanisms
Transducer Effector/Response
Gi/Go family
Gq/G11 family 		Potassium channel
Calcium channel
Comments:  In CHO cells stably expressing CFTR, the endogenous P2Y1 receptor shifts its coupling to Gi/Go [34]
References:  14,33
Tissue Distribution
Placenta > prostate > brain > intestine > skeletal muscle, heart > macrophages > pituitary, lung > pancreas > spleen, foetal liver > adipose> stomach, lymphocytes > liver, kidney.
Species:  Human
Technique:  RT-PCR.
References:  35
Nucleus accumbens >> putamen > caudate nucleus, striatum > parahippocampal gyrus > hypothalamus, globus pallidus > cingulate gyrus, hippocampus > amygdala, medula oblongata > cerebellum, locus coeruleus, medial frontal gyrus, superior frontal gyrus, spinal cord > thalamus > substantia nigra.
Species:  Human
Technique:  RT-PCR.
References:  35
Blood platelets.
Species:  Human
Technique:  RT-PCR
References:  27,31
GI tract: myenteric plexus, submucosal plexus, intestinal crypts of the ileum and along the lumen of the villi.
Species:  Mouse
Technique:  in situ hybridisation.
References:  19
Heart, skeletal muscle > brain, spleen, lung, liver, kidney.
Species:  Rat
Technique:  Northern blotting.
References:  48
Sensory ganglia: dorsal root ganglia (DRG), nodose ganglion (NG) and trigeminal ganglion (TG).
Species:  Rat
Technique:  RT-PCR and Immunohistochemistry.
References:  39
Expression Datasets

Click here to show/hide data

Log average relative transcript abundance in mouse tissues measured by qPCR from Regard, J.B., Sato, I.T., and Coughlin, S.R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell, 135(3): 561-71. [PMID:18984166] [Raw data: website]

There should be a chart of expression data here, you may need to enable JavaScript!
Functional Assays
Voltage clamp technique used to measure the ATP-evoked membrane current in Xenopus oocytes transfected with the P2Y1 receptor.
Species:  Rat
Tissue:  Xenopus oocytes.
Response measured:  Membrane current produced.
References:  48
Measurement of [Ca2+]i levels in Jurkat cells transfected with the P2Y1 receptor.
Species:  Human
Tissue:  Jurkat cells.
Response measured:  Increase in [Ca2+]i levels.
References:  21,31
Measurement of N-type Ca2+ channel currents in rat superior cervical ganglion (SCG) cells expressing the rat P2Y1 receptor.
Species:  Rat
Tissue:  Rat SCG cells.
Response measured:  Inhibition of N-type Ca2+ currents.
References:  13
Measurement of [Ca2+]i in human astrocytoma cells stably expressing the human P2Y1 receptor.
Species:  Human
Tissue:  1321N1 human astrocytoma cells.
Response measured:  Rapid increase in [Ca2+]i.
References:  37
Measurement of [Ca2+]i in rat glioma C6 cells endogenously expressing P2Y1 and P2Y2 receptors.
Species:  Rat
Tissue:  Glioma C6 cells.
Response measured:  Increase in [Ca2+]i via depletion of IP3-sensitive intracellular Ca2+ stores (PLC stimulation) and influx of extracellular Ca2+.
References:  40
Measurement of IP3 levels in response to selective P2Y1 receptor agonists in HEK 293 cells endogenously expressing the P2Y1 and P2Y2 receptors.
Species:  Human
Tissue:  HEK 293 cells.
Response measured:  Increase in IP3 accumulation.
References:  42
Measurement of Ca2+ levels in response to the P2Y1 agonist ADP in mouse peritoneal macrophages.
Species:  Mouse
Tissue:  Peritoneal macrophages.
Response measured:  Increase in [Ca2+]i.
References:  9
Measurement of K2+ current using patch-clamping of SCG cells transfected with the P2Y1 receptor and GIRK1 and GIRK2 channels.
Species:  Rat
Tissue:  SCG neurons.
Response measured:  Transient activation of GIRK current followed by inactivation.
References:  44
Following mechanical stimulation of an individual 1321N1 cell, measurement of Ca2+ propagation in 1321N1 cells transfected with the P2Y1 cells.
Species:  Rat
Tissue:  1321N1 cells.
Response measured:  Ca2+ wave only spread to cells expressing the P2Y1 receptor. P2Y1 is not required for the initiation of the wave.
References:  16
Measurement of K+ currents in primary cultures of pyramidal hippocampal neurons
Species:  Rat
Tissue:  Hippocampal primary neurons
Response measured:  Inhibition of the M-type K+ current
References:  14
Physiological Functions
Mitogenic effects.
Species:  Rat
Tissue:  Aortic smooth muscle cells.
References:  11
Smooth muscle relaxation.
Species:  Mouse
Tissue:  GI tract: stomach fundus, duodenum, ileum and colon.
References:  19
Vasodilation through the NO/cGMP pathway.
Species:  Rat
Tissue:  Arterial mesenteric bed.
References:  4
Platelet shape change.
Species:  Human
Tissue:  Platelets.
References:  27
Induction of platelet aggregation.
Species:  Human
Tissue:  Blood platelets.
References:  21
Release of IL-6 stimulation and enhanced neuroprotection
Species:  Rat
Tissue:  Primary hippocampal astrocytes
References:  15
GFAP and GDNF production under ischemic conditions
Species:  Rat
Tissue:  Astrocytes
References:  45
Atherosclerosis enhancement
Species:  Mouse
Tissue:  Aorta
References:  20
Glutamate efflux
Species:  Rat
Tissue:  Spinal cord astrocytes
References:  50
Endothelial cell migration
Species:  Human
Tissue:  HUVEC
References:  43
Regulation of EGF activity
Species:  Human
Tissue:  Epithelial cells
References:  3
Physiological Consequences of Altering Gene Expression
P2Y1 receptor deficiency resulted in a reduction of atherosclerosis in ApoE knockout mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  20
In vivo knockdown of the P2Y1 receptor by administration of short hairpin RNA selectively impairs the migration of neural progenitors to the subventricular zone
Species:  Mouse
Tissue: 
Technique:  RNAi
References:  33
P2Y1 receptor knockout mice exhibit increased bleeding time and increased protection from collagen- and ADP-induced thromboembolism.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  12
P2Y1 receptor knockout mice show no obvious abnormalities in their development, survival or reproduction, and have normal platelet morphology and count.
However, they have inpaired platelet aggregation in response to ADP and other agonists, and resistance to thromboembolism.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  30
P2Y1 knockout mice are protected from renal disease and resistant to capillary loss during passive crescentic glomerulonephritis
Species:  Mouse
Tissue: 
Technique:  knockout by gene targeting in embryonic stem cells
References:  24
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
P2ry1tm1Gac P2ry1tm1Gac/P2ry1tm1Gac
involves: 129S2/SvPas * C57BL/6		 MGI:105049  MP:0002551 abnormal blood coagulation PMID: 10606627 
P2ry1tm1Bhk P2ry1tm1Bhk/P2ry1tm1Bhk
involves: 129P2/OlaHsd * C57BL/6 * DBA/2		 MGI:105049  MP:0005464 abnormal platelet physiology PMID: 10502826 
P2ry1tm1Bhk P2ry1tm1Bhk/P2ry1tm1Bhk
involves: 129P2/OlaHsd * C57BL/6 * DBA/2		 MGI:105049  MP:0003422 abnormal thrombolysis PMID: 10502826 
P2ry1tm1Gac P2ry1tm1Gac/P2ry1tm1Gac
involves: 129S2/SvPas * C57BL/6		 MGI:105049  MP:0009549 decreased platelet aggregation PMID: 10606627 
P2ry1+|P2ry1tm1Gac P2ry1tm1Gac/P2ry1+
involves: 129S2/SvPas * C57BL/6		 MGI:105049  MP:0009549 decreased platelet aggregation PMID: 10606627 
P2ry1tm1Gac P2ry1tm1Gac/P2ry1tm1Gac
involves: 129S2/SvPas * C57BL/6		 MGI:105049  MP:0005606 increased bleeding time PMID: 10606627 
P2ry1tm1Bhk P2ry1tm1Bhk/P2ry1tm1Bhk
involves: 129P2/OlaHsd * C57BL/6 * DBA/2		 MGI:105049  MP:0005606 increased bleeding time PMID: 10502826 
Biologically Significant Variants
A silent polymorphism in the coding seguence of the P2Y1 gene is associated with different platelet reactivity to ADP
Type:  Single nucleotide polymorphism
Species:  Human
References:  23
The presence of a polymorphism appears to confer an attenuated antiplatelet effect during aspirin treatment in healthy Chinese subjects
Type:  Single nucleotide polymorphism
Species:  Human
References:  32
General Comments
In all species, the P2Y1 receptor is selective for adenine nucleotides. Presence of P2Y1 receptors has been reported in mitochondria of astrocytes and C6 cells, although its role in these sub-cellular structures remains unclear [29].

REFERENCES

Show »

1. Ayyanathan, K., Webbs, T. E., Sandhu, A. K., Athwal, R. S., Barnard, E. A. and Kunapuli, S. P. (1996) Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun, 218: 983-988. [PMID:8579591]

2. Boyer, J. L., Romero-Avila, T., Schachter, J. B. and Harden, T. K. (1996) Identification of competitive antagonists of the P2Y1 receptor. Mol. Pharmacol., 50: 1323-1329. [PMID:8913364]

3. Buvinic, S., Bravo-Zehnder, M., Boyer, J. L., Huidobro-Toro, J. P. and Gonzalez, A. (2007) Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells. J Cell Sci, 120: 4289-4301. [PMID:18057028]

4. Buvinic, S., Briones, R. and Huidobro-Toro, J. P. (2002) P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol, 136: 847-856. [PMID:12110609]

5. Cattaneo, M., Lecchi, A., Ohno, M., Joshi, B. V., Besada, P., Tchilibon, S., Lombardi, R., Bischofberger, N., Harden, T. K. and Jacobson, K. A. (2004) Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. Biochem Pharmacol,, 68: 1995-2002. [PMID:15476670]

6. Chao, H; Turdi, H; Herpin, TF; Roberge, JY; Liu, Y; Schnur, DM; Poss, MA; Rehfuss, R; Hua, J; Wu, Q; et al.. (2013) Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y(1) Antagonists. J. Med. Chem.,  [Epub ahead of print]. [PMID:23368907]

7. Chhatriwala, M; Ravi, RG; Patel, RI; Boyer, JL; Jacobson, KA; Harden, TK. (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J. Pharmacol. Exp. Ther., 311 (3): 1038-43. [PMID:15345752]

8. Costanzi, S; Santhosh Kumar, T; Balasubramanian, R; Kendall Harden, T; Jacobson, KA. (2012) Virtual screening leads to the discovery of novel non-nucleotide P2Y₁ receptor antagonists. Bioorg. Med. Chem., 20 (17): 5254-61. [PMID:22831801]

9. Coutinho-Silva, R., Ojcius, D. M., Gorecki, D. C., Persechini, P. M., Bisaggio, R. C., Mendes, A. N., Marks, J., Burnstock, G. and Dunn, P. M. (2005) Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem Pharmacol, 69: 641-655. [PMID:15670583]

10. Ding, Z., Tuluc, F., Bandivadekar, K. R., Zhang, L., Jin, J. and Kunapuli, S. P. (2005) Arg333 and Arg334 in the COOH terminus of the human P2Y1 receptor are crucial for Gq coupling. Am J Physiol Cell Physiol, 288: 559-567. [PMID:15509659]

11. Erlinge, D., Hou, M., Webb, T. E., Barnard, E. A. and Moller, S. (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem. Biophys. Res. Commun., 248: 864-870. [PMID:9704019]

12. Fabre, J. E., Nguyen, M., Latour, A., Keifer, J. A., Audoly, L. P., Coffman, T. M. and Koller, B. H. (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat. Med., 5: 1199-1202. [PMID:10502826]

13. Filippov, A. K., Brown, D. A. and Barnard, E. A. (2000) The P2Y1 receptor closes the N-type Ca2+channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists. Br. J. Pharmacol., 129: 1063-1066. [PMID:10725253]

14. Filippov, A. K., Choi, R. C., Simon, J., Barnard, E. A. and Brown, D. A. (2006) Activation of P2Y1 nucleotide receptors induces inhibition of the M-type K+ current in rat hippocampal pyramidal neurons. J. Neurosci., 26: 9340-9348. [PMID:16957090]

15. Fujita, T., Tozaki-Saitoh, H. and Inoue, K. (2009) P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia, 57: 244-257. [PMID:18756525]

16. Gallagher, C. J. and Salter, M. W. (2003) Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors. J Neurosci, 23: 6728-6839. [PMID:12890765]

17. Gao, Z. G., Mamedova, L. K., Chen, P. and Jacobson, K. A. (2004) 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. Biochem Pharmacol, 68: 1985-1993. [PMID:15476669]

18. Gao, Z. G., Mamedova, L., Tchilibon, S., Gross, A. S. and Jacobson, K. A. (2004) 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochem Pharmacol., 68: 231-237. [PMID:15193995]

19. Giaroni, C., Knight, G. E., Ruan, H. Z., Glass, R., Bardini, M., Lecchini, S., Frigo, G. and Burnstock, G. (2002) P2 receptors in the murine gastrointestinal tract. Neuropharmacology, 43: 1313-1323. [PMID:12527481]

20. Hechler, B., Freund, M., Ravanat, C., Magnenat, S., Cazenave, J. P. and Gachet, C. (2008) Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation, 118: 754-763. [PMID:18663083]

21. Hechler, B., Leon, C., Vial, C., Vigne, P., Frelin, C., Cazenave, J. P. and Gachet, C. (1998) The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood, 92: 152-159. [PMID:9639511]

22. Hechler, B., Vigne, P., Léon, C., Breittmayer, J. P., Gachet, C. and Frelin, C. (1998) ATP derivatives are antagonists of the P2Y1receptor: similarities to the platelet ADP receptor. Mol. Pharmacol., 53: 727-733. [PMID:9547364]

23. Hetherington, S. L., Singh, R. K., Lodwick, D., Thompson, J. R., Goodall, A. H. and Samani, N. J. (2005) Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol., 25: 252-257. [PMID:15514209]

24. Hohenstein, B., Renk, S., Lang, K., Daniel, C., Freund, M., Leon, C., Amann, K. U., Gachet, C. and Hugo, C. P. (2007) P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis. J Am Soc Nephrol., 18: 494-505. [PMID:17215444]

25. Houston, D., Ohno, M., Nicholas, R. A., Jacobson, K. A. and Harden, T. K. (2006) [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors. Br J Pharmacol., 147: 459-467. [PMID:16299552]

26. Janssens, R., Communi, D., Pirotton, S., Samson, M., Parmentier, M. and Boeynaems, J. M. (1996) Cloning and tissue distribution of the human P2Y1 receptor. Biochem Biophys Res Commun, 221: 588-593. [PMID:8630005]

27. Jin, J., Daniel, J. L. and Kunapuli, S. P. (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem., 273: 2030-2034. [PMID:9442040]

28. Kim, HS; Ohno, M; Xu, B; Kim, HO; Choi, Y; Ji, XD; Maddileti, S; Marquez, VE; Harden, TK; Jacobson, KA. (2003) 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. J. Med. Chem., 46 (23): 4974-87. [PMID:14584948]

29. Krzeminski, P., Misiewicz, I., Pomorski, P., Kasprzycka-Guttman, T. and Baranska, J. (2007) Mitochondrial localization of P2Y1, P2Y2 and P2Y12 receptors in rat astrocytes and glioma C6 cells. Brain Res Bull, 71: 587-592. [PMID:17292801]

30. Leon, C., Hechler, B., Freund, M., Eckly, A., Vial, C., Ohlmann, P., Dierich, A., LeMeur, M., Cazenave, J. P. and Gachet, C. (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1receptor-null mice. J. Clin. Invest., 104: 1731-1737. [PMID:10606627]

31. Leon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J. P. and Gachet, C. (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett., 403: 26-30. [PMID:9038354]

32. Li, Q., Chen, B. L., Ozdemir, V., Ji, W., Mao, Y. M., Wang, L. C., Lei, H. P., Fan, L., Zhang, W., Liu, J. and Zhou, H. H. (2007) Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics, 8: 577-586. [PMID:17559347]

33. Liu, X., Hashimoto-Torii, K., Torii, M., Haydar, T. F. and Rakic, P. (2008) The role of ATP signaling in the migration of intermediate neuronal progenitors to the neocortical subventricular zone. Proc Natl Acad Sci USA, 105: 11802-11807. [PMID:18689674]

34. Marcet, B., Chappe, V., Delmas, P. and Verrier, B. (2004) Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells. J Pharmacol Exp Ther., 309: 533-539. [PMID:14742736]

35. Moore, D. J., Chambers, J. K., Wahlin, J. P., Tan, K. B., Moore, G. B., Jenkins, O., Emson, P. C. and Murdock, P. R. (2001) Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta, 1521: 107-119. [PMID:11690642]

36. Morales-Ramos, A.I., Mecom, J.S., Kiesow, T.J., Graybill, T.L., Brown, G.D., Aiyar, N.V., Davenport, E.A., Kallal, L.A., , , Li, P., Londregan, A.T., Morrow, D.M., Senadhi, S., Thalji, R.K., Zhao, S., Burns-Kurtis, C.L. and Marino, J.P. (2008) Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists. Bioorg Med Chem Lett, 18: 6222-6226. [PMID:18926700]

37. Palmer, R. K., Boyer, J. L., Schachter, J. B., Nicholas, R. A. and Harden, T. K. (1998) Agonist action of adenosine triphosphates at the human P2Y1receptor. Mol. Pharmacol., 54: 1118-1123. [PMID:9855642]

38. Pfefferkorn, JA; Choi, C; Winters, T; Kennedy, R; Chi, L; Perrin, LA; Lu, G; Ping, YW; McClanahan, T; Schroeder, R; et al.. (2008) P2Y1 receptor antagonists as novel antithrombotic agents. Bioorg. Med. Chem. Lett., 18 (11): 3338-43. [PMID:18445527]

39. Ruan, H. Z. and Burnstock, G. (2003) Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem Cell Biol, 120: 415-426. [PMID:14564529]

40. Sabala, P., Czajkowski, R., Przybylek, K., Kalita, K., Kaczmarek, L. and Baranska, J. (2001) Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells. Br J Pharmacol, 132: 393-402. [PMID:11159687]

41. Schachter, J. B. and Harden, T. K. (1997) An examination of deoxyadenosine 5'(α-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1receptor. Br. J. Pharmacol., 121: 338-344. [PMID:9154346]

42. Schachter, J. B., Sromek, S. M., Nicholas, R. A. and Harden, T. K. (1997) HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors. Neuropharmacology, 36: 1181-1187. [PMID:9364473]

43. Shen, J. and DiCorleto, P. E. (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res,, 102: 448-456. [PMID:18174464]

44. Simon, J., Filippov, A. K., Goransson, S., Wong, Y. H., Frelin, C., Michel, A. D., Brown, D. A. and Barnard, E. A. (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem, 277: 31390-31400. [PMID:12080041]

45. Sun, J. J., Liu, Y. and Ye, Z. R. (2008) Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways. Neurosci Bull, 24: 231-243. [PMID:18668152]

46. Takasaki, J., Kamohara, M., Saito, T., Matsumoto, M., Matsumoto, S., Ohishi, T., Soga, T., Matsushime, H. and Furuichi, K. (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol, 60: 432-439. [PMID:11502873]

47. Thalji, RK; Aiyar, N; Davenport, EA; Erhardt, JA; Kallal, LA; Morrow, DM; Senadhi, S; Burns-Kurtis, CL; Marino, JP. (2010) Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists. Bioorg. Med. Chem. Lett., 20 (14): 4104-7. [PMID:20542694]

48. Tokuyama, Y., Hara, M., Jones, E. M., Fan, Z. and Bell, G. I. (1995) Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun, 211: 211-218. [PMID:7779087]

49. Waldo, G. L., Corbitt, J., Boyer, J. L., Ravi, G., Kim, H. S., Ji, X. D., Lacy, J., Jacobson, K. A. and Harden, T. K. (2002) Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist. Mol Pharmacol, 62: 1249-1257. [PMID:12391289]

50. Zeng, J. W., Liu, X. H., He, W. J., Du, L., Zhang, J. H., Wu, X. G. and Ruan, H. Z. (2008) Inhibition of ATP-induced glutamate release by MRS2179 in cultured dorsal spinal cord astrocytes. Pharmacology, 82: 257-263. [PMID:18841035]

To cite this database page, please use the following:

Maria-Pia Abbracchio, Jean-Marie Boeynaems, José L. Boyer, Geoffrey Burnstock, Stefania Ceruti, Marta Fumagalli, Christian Gachet, Rebecca Hills, Robert G. Humphries, Kenneth A. Jacobson, Charles Kennedy, Brian F. King, Davide Lecca, Maria Teresa Miras-Portugal, Gary A. Weisman.
P2Y receptors: P2Y1 receptor. Last modified on 26/02/2013. Accessed on 19/06/2013. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=323.


Contact us | Print | Back to top | Help